NanoViricides Inc. (NNVC)

[rearden]

My opinion only:

Any one of the following:

1. Successful scale-up of FluCide for tox testing AND the associated accompanying tests to determine the hang-around time for the micelles.

2. News of successful testing of EbolaCide from USAMRIID.

3. FDA fast-tracking of the anti-herpes product.

4. From out of nowhere: Successful testing of anti-MERS or DengueCide.

5. Someone with a ton of $$$$ and gravitas buys into the company.

I'm sure I am missing something because there are so many irons in the fire.

Until then, we watch the slow leak.

Still long with a shrinking portfolio.